T

he in silico approach to drug development just got a taste of validation, thanks to some intriguing new research from University of California, San Francisco. A drug cherry-picked with algorithms has behaved as expected: It’s helped shrink tumors in animal models.

The UCSF researchers have created a computational method to delve through enormous amounts of open-access data to find novel drugs — and also discover new ways to repurpose existing drugs. The work was just published in Nature Communications.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Interestingly, there is evidence that certain cancers may be caused by parasites, certain cancers by fungal infections, etc. Perhaps it is not surprising that anti-parasitics and anti-fungals would be effective in those cases.

    • Cancer is promoted by low hygiene yes, but it is more encouraged by the gene mutations.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.